Skip to content

To evaluate the safety and efficacy of Plum serum in Hair Growth

A clinical study to evaluate the safety and efficacy of Plum serum in Hair Growth and hairfall with Phototrichogram. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062978
Enrollment
36
Registered
2024-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product- Hair Growth Serum : Dose: approx. 0.5 to 1 ml with help of dropper on bald area with gentle massage. Twice a day Route of Administration: Topical Duration: 86 days Control

Sponsors

Pureplay Skin Sciences India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Indian or Asian female and male subjects with max Female : Male Ratio – 80:20 with Stage 2 and 3 2. Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptomin the process of an exploratory checkup) 3. Between 25 and 40 years of age. 4. Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)

Exclusion criteria

Exclusion criteria: • Being pregnant or breastfeeding or having stopped to breastfeed in the past three months • Having refused to give her assent by not signing the consent form • Taking part in another study liable to interfere with this study • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area • Being insulin-dependent diabetic or non insulindependent diabetic with a recent therapy (less than 6 months) • Having a progressive asthma (either under treatment or last fit in the last 2 years) • Being epileptic • Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6months) • Having cutaneous hypersensitivity • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products • Following a chronic or intermittent medicinal treatment comprising any of the following products : aspirin-based products, antiinflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past6 months • Having changed her cosmetic habits except those required by the protocol in the 14 dayspreceding the start of the study on the studied anatomic unit • Having applied a cosmetic product on the studied areas the first day of the study (except theusual shampoo)

Design outcomes

Primary

MeasureTime frame
Change in Hair growthTimepoint: T0min, T+2 days, T+28 days ,T+30 days, T+56 days T+58 days, T+84 days and T+86 days

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026